LBO — PRESENCE SAINTS MARY & ELIZABETH MED
IRR: 25.6% | MOIC: 3.12x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
25.6%
IRR
3.12x
MOIC
$138.5M
Entry EV
$288.3M
Exit EV
$71.3M
Equity Invested
Sources & Uses
S&UTotal · $138.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $53.8M | 38.8% | |
| Sub Debt | $13.5M | 9.7% | |
| Equity | $71.3M | 51.5% | |
| Enterprise Value | $134.5M | 97.1% | |
| Transaction Fees | $4.0M | 2.9% | |
| Total Uses | $138.5M | 100.0% |
Interpretation
INTAt 3.12x MOIC and 25.6% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $27.5M |
| Exit Ev | $288.3M |
| Net Debt At Exit | $65.7M |
| Equity At Exit | $222.5M |
| Equity Invested | $71.3M |
| Total Value Created | $151.2M |
| Value From Growth | $147.0M |
| Value From Multiple | $6.7M |
| Value From Deleveraging | $1.5M |